Sign In
Buy RBGLY
$12.13
+0.0180 (+0.149%)
At Close: Jun 03, 2026
Reckitt Benckiser up 10% after being cleared of liability in preterm formula case
04:24am, Friday, 01'st Nov 2024
Shares in British consumer goods company Reckitt Benckiser jumped over 10% on Friday after the company, along with U.S.-based Abbott Labs, was cleared of liability in a preterm formula case.
Abbott, Reckitt cleared of liability in latest preterm formula case
05:03pm, Thursday, 31'st Oct 2024
Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature ba
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
03:50pm, Wednesday, 30'th Oct 2024
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for
Reckitt Benckiser Group plc (RBGPF) Q3 2024 Earnings Call Transcript
01:57pm, Wednesday, 23'rd Oct 2024
Reckitt Benckiser Group plc (OTCPK:RBGPF) Q3 2024 Results Conference Call October 23, 2024 3:30 AM ET Company Participants Nick Ashworth - Head of Investor Relations Kris Licht - Chief Executive Offic
RBGLY or CLX: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 23'rd Oct 2024
Investors interested in Soap and Cleaning Materials stocks are likely familiar with Reckitt Benckiser Group PLC (RBGLY) and Clorox (CLX). But which of these two stocks offers value investors a better
Reckitt Benckiser results 'good enough' but not out of the woods yet
10:42am, Wednesday, 23'rd Oct 2024
Shares in Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) rose almost 4% to a six-month high after the Cilit Bang, Nurofen and Durex maker reported a smaller fall in sales than investors feared. Thir
Reckitt Benckiser posts drop in revenue as nutrition wing weighs
02:54am, Wednesday, 23'rd Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has said sales fell over the third quarter as revenue from its nutrition wing slumped. Like for like revenue declined by 0.5% to £3,46 billion during th
Healthcare helps Reckitt beat quarterly sales estimates
02:13am, Wednesday, 23'rd Oct 2024
Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.
Reckitt promotional push threatens sales as earnings loom
06:34am, Thursday, 17'th Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) will offer up third-quarter results next Wednesday, 23 October reflecting what analysts believe will have seen a drop in sales. Barclays analysts forecas
RBGLY vs. CLX: Which Stock Is the Better Value Option?
12:46pm, Monday, 07'th Oct 2024
Investors looking for stocks in the Soap and Cleaning Materials sector might want to consider either Reckitt Benckiser Group PLC (RBGLY) or Clorox (CLX). But which of these two stocks is more attracti
Reckitt Benckiser could return £12.5bn after overhaul, says leading investment bank
06:46am, Friday, 04'th Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) could return up to £12.5 billion to shareholders, about 40% of its market value, as part of a major strategic overhaul, according to Barclays. The compa
Reckitt Benckiser has sales and legal risks aplenty as third-quarter results approach
10:22am, Wednesday, 02'nd Oct 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is facing multiple challenges ahead of its third-quarter results, with Jefferies forecasting a -1% drop in like-for-like sales. Key reasons for the limp
Abbott, Reckitt face trial over premature baby formula amid alarm from doctors
08:03am, Monday, 30'th Sep 2024
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she
Reckitt in talks to sell £6bn homecare portfolio, reports Bloomberg
07:47am, Wednesday, 18'th Sep 2024
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) is in talks with interested parties to dispose of its £6 billion homecare portfolio, which includes household brands Air Wick, Mortein, Calgon and Cilli
Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports
01:41pm, Tuesday, 17'th Sep 2024
Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesd
